Dr. Monica Raimo the Director of Product and Process Development at Glycostem Therapeutics, which she joined in 2018. She is strongly focused on advancing cell therapy innovation in the development of clinically compliant non-engineered and engineered allogeneic NK cells. She has a PhD in Molecular Oncology from the University of Turin, Italy, and an executive MBA from Quantic school of Business.